ITIF：2026年关于美国贸易代表办公室对其德国在创新药品产品方面持续低估的第301条款调查的意见（英文版）

he Information Technology and Innovation Foundation (ITIF)—an independent, nonprofit, nonpartisan research and educational institute focused on the intersection of technological innovation and public policy—appreciates the opportunity to provide information to the Office of the U.S. Trade Representative (USTR) regarding its Section 301 investigation of “Germany’s Persistent Underpayment for Innovative Pharmaceutical Products.”